FTC Accuses Drug Middlemen Of Raising Insulin Prices
By Matthew Perlman · September 20, 2024, 12:00 PM EDT
The Federal Trade Commission on Friday accused the three largest pharmacy benefits managers, Caremark Rx, Express Scripts and OptumRx, of artificially inflating insulin prices by relying on unfair rebate schemes that...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login